Prostate cancer decisions — 2020
1,445 indexed Board decisions in 2020.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: GrantedJuly 2020
The Board has determined that the Veteran's service-connected disabilities result in permanent loss of use of his left foot, and therefore grants eligibility for financial assistance in purchasing an automobile with adaptive equipment.
- Whole decision: Remanded (sent back)July 2020
The Veteran's claims for increased ratings are being remanded due to the need for additional VA examinations and the identification of outstanding treatment records.
- Whole decision: GrantedJuly 2020
The Veteran's prostate cancer was rated at 100% effective March 28, 2016. An earlier effective date of December 4, 2015 is granted for the 100% rating.,A 20% rating for prostate cancer residuals is restored from September 6, 2012.
- Whole decision: GrantedJuly 2020
The Board has granted service connection for prostate cancer, finding that the Veteran was exposed to herbicide agents during his time in Thailand and thus meeting the presumptive criteria established by VA.
- Whole decision: GrantedJuly 2020
The Board has granted service connection for prostate cancer residuals effective March 6, 2006. The Veteran's claim was remanded due to the need to consider an initial compensable rating and a TDIU.
- Whole decision: Remanded (sent back)July 2020
The Veteran's prostate cancer residuals are currently rated at 40 percent, and the Board has decided to remand the case for further development regarding whether his prostate cancer is active or inactive.
- Whole decision: Remanded (sent back)July 2020
The Board has remanded the issues of service connection for various disabilities, including cervical spine disability, back disability, bilateral shoulder disability, bilateral hip disability, bilateral knee disability, bilateral ankle disability, bilateral foot disability, rhinitis, bronchitis, asthma, heart disability, prostate cancer, and urinary incontinence. The reasons are that the Veteran failed to report to scheduled VA examinations for these disabilities.
- Whole decision: DeniedJuly 2020
The Board denied the Veteran's claims for service connection for prostate cancer and a bladder disability, finding that there was no evidence linking these conditions to his military service or exposure to contaminated water at Camp Lejeune.
- Whole decision: Remanded (sent back)July 2020
The Veteran's claim for a rating in excess of 60 percent for his service-connected residuals of prostate cancer is denied. The VA has also remanded the issues regarding abdominal scars and erectile dysfunction associated with prostate cancer.
- Whole decision: GrantedJuly 2020
The Veteran's appeal for a higher rating for prostate cancer residuals was denied, but the claim for SMC based on loss of use of a creative organ (erectile dysfunction) due to service-connected prostate cancer was granted.
- Whole decision: Remanded (sent back)July 2020
The Board has denied service connection for bilateral hearing loss and tinnitus, finding that the preponderance of evidence is against a link to active service. The Veteran's prostate cancer, impotency, urinary continence, and residuals of fractured left knee are also remanded for further development.,Service connection for prostate cancer, impotency (secondary to prostate cancer), urinary continence (secondary to prostate cancer), and residuals of fractured left knee (including arthritis) is remanded due to the need for additional evidence.
- Whole decision: Remanded (sent back)July 2020
The Board has remanded the claims for hypertension, prostate cancer, and erectile dysfunction due to in-service exposure to chemical agents. Additional development is needed to corroborate the Veteran's claimed exposures.
- Whole decision: DeniedJuly 2020
The Board denied service connection for ischemic heart disease and upheld the reduction in rating for prostate cancer, both effective April 1, 2013.
- Whole decision: Remanded (sent back)July 2020
The Board has remanded the cases due to insufficient evidence regarding the Veteran's exposure to Agent Orange and firefights in the Korean DMZ. The VA needs to contact the JSRRC for unit records to determine if the Veteran was exposed to these factors during his service.
- Whole decision: DeniedJuly 2020
The Board denied service connection for a prostate disability, finding that the evidence did not support a link to active service or any related conditions. The Veteran's prostate cancer was diagnosed many years after separation from service.
- Whole decision: DismissedJuly 2020
The Board has dismissed all service connection claims as the Veteran died during the appeal process.
- Whole decision: Remanded (sent back)July 2020
The Veteran's claim for a higher evaluation of prostate cancer residuals is denied. The issue of entitlement to TDIU remains pending and will be remanded for further development.
- Whole decision: DismissedJuly 2020
The Board has dismissed all claims of service connection and evaluation for the listed conditions due to the Veteran's withdrawal of his appeal.
- Whole decision: DismissedJuly 2020
The Board dismissed the Veteran's appeals for service connection of COPD and prostate cancer as he withdrew his appeals in February 2020.
- Whole decision: Remanded (sent back)July 2020
The Board has remanded the cases of ischemic heart disease, prostate cancer, infertility, and PTSD for further development. The Veteran's private treatment records need to be obtained from Dr. Higgins and Dr. Evers.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.